CV Sciences Targets 2026 Cash-Flow Breakeven, Non-CBD Push: CV Sciences (Seeking Alpha, Mar 26, 2026) targets cash-flow breakeven through 2026 and plans non-cannabinoid SKUs with margin expansion as the primary lever. 👈 Read full analysis #CVSciences #CashFlow #Breakeven #Cannabinoids #NonCBD
0
0
0
0